Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Masellis AM et al. – Complete response of multiple liver and peritoneal metastases and reduction in size with increasing calcification of the pancreatic mass occurred in this patient after 18 months of treatment. This report documents the individual response to effective and well–tolerated treatment regimens integrating available drugs.

Related Articles

Intratumoral delivery of shRNA targeting cyclin D1 attenuates pancreatic cancer growth
Cancer Gene Therapy, 10/27/09    Relevance Score: 67%

HMGA1 correlates with advanced tumor grade and decreased survival in pancreatic ductal adenocarcinoma
Modern Pathology, 10/13/09    Relevance Score: 67%

Serum tumor antigen REG4 as a diagnostic biomarker in pancreatic ductal adenocarcinoma
Journal of Gastroenterology, 10/02/09    Relevance Score: 67%

Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations and risk for pancreatic adenocarcinoma
Cancer, 11/06/09    Relevance Score: 66%

Novel agents for the treatment of adenocarcinoma of the pancreas
Expert Review of Anticancer Therapy, 10/22/09    Relevance Score: 66%

Today in Hepatobiliary/Pancreas...keeping you current

Expression of IL-13Ralpha2 in liver cancer cells and its effect on targeted therapy of liver cancer
Journal of Cancer Research & Clinical Oncology, 11/23/09

L1 Cell Adhesion Molecule Is a Novel Independent Poor Prognostic Factor of Extrahepatic Cholangiocarcinoma
Clinical Cancer Research, 11/20/09

Oncostatin M and leukemia inhibitory factor increase hepcidin expression in hepatoma cell lines
International Journal of Hematology, 11/20/09

Today in Pharmacology/Therapy...keeping you current

Valproic acid restores ERalpha and antiestrogen sensitivity to ERalpha-negative breast cancer cells
Molecular and Cellular Endocrinology, 11/24/09

Nuclear IRS-1 predicts tamoxifen response in patients with early breast cancer
Breast Cancer Research and Treatment, 11/24/09

Successful treatment of autoimmune and lymphoproliferative complications of patients with intrinsic B-cell immunodeficiencies with Rituximab
British Journal of Haematology, 11/24/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address